JIANBING ZHANG | PARTNER | GUANGZHOU

Previously working as partner of IDG Capital; board member for several publicly listed and leading companies in the biomedical sector with more than 20 years of practical experience in pharmaceutical R&D, drug marketing/sales, and investments; ranked several times as the best healthcare investor in China

  • •Guangdong HEC Pharm (leading the $1 B equity investment)

    •Kelun-Biotech (license out deal with Merck with $9.3 B)

    •MGI Tech Co., Ltd (market cap of $5 B)

    •Ping An Good Doctor (market cap of $3.2 B)

    •Shanghai Model Organisms (market cap of $400 M), etc.

  • •Fund Practitioner Qualification Certificate

    •Shenzhen Stock Exchange Independent Director Qualification Certificate

    •National Licensed Pharmacist Qualification Certificate

    •Bachelor Degree in Biochemistry from Nanjing Tech University

    •MBA from Cheung Kong Business School